A MULTICENTER RANDOMIZED CONTROLLED TRIAL OF SURVEILLANCE VERSUS ENDOSCOPIC THERAPY FOR BARRETT’S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: THE SURVENT TRIAL STUDY RATIONALE, METHODOLOGY, INNOVATION AND IMPLICATIONS

Posted on June 6, 2022 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.